Description

The increasing world demand for human biologics cannot be met by current production platforms based primarily on mammalian cell culture due to prohibitive cost and limited scalability [1]. Recent progress

The increasing world demand for human biologics cannot be met by current production platforms based primarily on mammalian cell culture due to prohibitive cost and limited scalability [1]. Recent progress in plant expression vector development, downstream processing, and glycoengineering has established plants as a superior alternative to biologic production [2–4].

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2014-06-02
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1155/2014/418064
    • Identifier Type
      International standard serial number
      Identifier Value
      2314-6133
    • Identifier Type
      International standard serial number
      Identifier Value
      2314-6141

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Chen, Q., Santi, L., & Zhang, C. (2014). Plant-Made Biologics. BioMed Research International, 2014, 1-3. doi:10.1155/2014/418064

    Machine-readable links